tallózása szerző szerint "Pipek, Orsolya Anna"

A találatok rendezése: Rendezés: Találatok:

  • Chemotherapy treatment is associated with altered PD-L1 expression in lung cancer patients 
    Rojko L; Reiniger, Lilla; Téglási, Vanda; Fábián, Katalin; Pipek, Orsolya Anna; Vágvölgyi, Attila; Agocs L; Fillinger J; Kajdacsi Z; Tímár, József; Döme, Balázs; Szállási, Zoltán; Moldvay, Judit (2018)
    OBJECTIVES: While the predictive value of programmed cell death ligand-1 (PD-L1) protein expression for immune checkpoint inhibitor therapy of lung cancer has been extensively studied, the impact of standard platinum-based ...
  • Fast and accurate mutation detection in whole genome sequences of multiple isogenic samples with IsoMut 
    Pipek, Orsolya Anna; Ribli, Dezső; Molnár, János; Póti Á; Krzystanek M; Bodor, András; Tusnády, Gábor; Szállási, Zoltán; Csabai, István; Szüts, Dávid (2017)
    Background: Detection of somatic mutations is one of the main goals of next generation DNA sequencing. A wide range of experimental systems are available for the study of spontaneous or environmentally induced mutagenic ...
  • Loss of BRCA1 or BRCA2 markedly increases the rate of base substitution mutagenesis and has distinct effects on genomic deletions 
    Zámborszky, Judit; Szikriszt, Bernadett; Gervai, Judit Zsuzsanna; Pipek, Orsolya Anna; Póti Á; Krzystanek M; Ribli, Dezső; Szalai-Gindl, János Márk; Csabai, István; Szállási, Zoltán; Swanton C; Richardson AL; Szüts, Dávid (2017)
    Loss-of-function mutations in the BRCA1 and BRCA2 genes increase the risk of cancer. Owing to their function in homologous recombination repair, much research has focused on the unstable genomic phenotype of BRCA1/2 mutant ...